Alopecia Areata — Patent Landscape

Aggregated US Orange Book patent estate across every approved drug for alopecia areata. 20 active patents protecting 2 drugs from 2+ originators. First major cliff: 2029. Daily refresh.

2
Approved drugs
20
Active US patents
49/100
Avg vulnerability
$1.2B
Annual revenue covered

Originators in Alopecia Areata

Companies holding active patents on drugs approved for this indication. Click through to each company's full patent dashboard.

Eli Lilly 17 patents Pfizer 3 patents

Cliff calendar — next 15 years

Patent expiries per year across all drugs treating alopecia areata. Each bar = one year. Y-axis scaled to peak year (9 patents).

2
29
6
31
9
32
2
34

Approved drugs ranked by patent estate

Drug Originator Active patents Avg vuln Revenue First cliff
Olumiant
baricitinib
 Eli Lilly 17 62 $1.2B 2029-03-10
Litfulo
Ritlecitinib Tosylate
 Pfizer 3 35 — 2034-12-03

Most attackable patents

Highest vulnerability scores in the indication — paragraph IV / IPR / design-around candidates.

Patent Drug Type Vuln Expiry
11806555 Olumiant method of use 76 2031-11-02
9737469 Olumiant method of use 76 2031-11-02
9737469 Olumiant method of use 76 2031-11-02
9737469 Olumiant method of use 76 2031-11-02
11806555 Olumiant method of use 76 2031-11-02
11806555 Olumiant method of use 76 2031-11-02
8420629 Olumiant method of use 75 2029-03-10
8420629 Olumiant method of use 75 2029-03-10
12077533 Litfulo method of use 75 2034-12-03
11045474 Olumiant method of use 70 2032-11-30

Strongest defences

Lowest vulnerability scores — pillars of the indication's IP fortress.

Patent Drug Type Vuln Expiry
8158616 Olumiant composition of matter 4 2032-05-31
8158616 Olumiant composition of matter 4 2032-05-31
9617258 Litfulo composition of matter 12 2034-12-03
8158616 Olumiant composition of matter 12 2032-05-31
12116368 Litfulo composition of matter 17 2041-10-17
9089574 Olumiant method of use 70 2032-11-30
9089574 Olumiant method of use 70 2032-11-30
11045474 Olumiant method of use 70 2032-11-30
11045474 Olumiant method of use 70 2032-11-30
11045474 Olumiant method of use 70 2032-11-30

Related